H.C. Wainwright Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating, Maintains Target Price $11
Wedbush Reiterates Outperform on Black Diamond Therapeutic, Maintains $16 Price Target
Black Diamond Therapeutic Analyst Ratings
TD Cowen Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating
Buy Rating on Black Diamond Therapeutics: Promising Early Results for BDTX-1535 in NSCLC Treatment
Black Diamond Therapeutic Analyst Ratings
Raymond James Initiates Black Diamond Therapeutics(BDTX.US) With Buy Rating, Announces Target Price $20
Black Diamond Therapeutic Analyst Ratings
Black Diamond Therapeutic Analyst Ratings
Black Diamond Therapeutic Analyst Ratings
Buy Rating Affirmed for Black Diamond Therapeutics Amid Strong Financials and Promising Clinical Trials
Black Diamond Therapeutics (BDTX) Gets a Buy From Piper Sandler
Black Diamond Therapeutic Analyst Ratings
Black Diamond Therapeutic Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Black Diamond Therapeutics (BDTX) and I-MAB (IMAB)
Black Diamond Therapeutic Analyst Ratings
Black Diamond Therapeutics (BDTX) Receives a Buy From TD Cowen
Analysts Are Bullish on These Healthcare Stocks: Black Diamond Therapeutics (BDTX), Enanta Pharmaceuticals (ENTA)
Analysts' Top Healthcare Picks: Black Diamond Therapeutics (BDTX), Amylyx Pharmaceuticals Inc (AMLX)
Black Diamond Therapeutic Analyst Ratings
No Data